Search Results | Showing 91 - 100 of 1646 results for "Study" |
| | | ... negative impact on consumers and contribute to a relationship breakdown between the customer and financial firm." In one case study with an unnamed fund, AFCA said it observed a "pattern of delays" in the fund's responses which affected its Internal ... |
| | | | ... analysed invest in real estate. Family offices from Europe, North America, Asia Pacific and Middle East took part in the study. The US leads the way for real estate-focused single family offices, followed closely by Germany. Residential, office and retail ... |
| | | | Australia's booming collectables market has reached $16.8 billion, a new study from eBay Australia shows. The second edition of the State of Collectables 2025 Report, compiled in conjunction with Deloitte Access Economics, found that coins (34%), toys ... |
| | | | Northern Trust's inaugural global study of 180 asset owners has mapped the pressures, both internal and external, they expect to face in the coming year. The study canvassed responses from senior leaders from pension funds, multi-managers, outsourced ... |
| | | | ... On March 31, ASX-listed Opthea announced it ceased the two major trials: COAST (Combination of OPT-302 with Aflibercept Study) and second Phase 3 trial ShORe (Study of OPT-302 in combination with Ranibizumab) in patients with wet AMD. "As previously ... |
| | | | ... intergenerational wealth transfer, many are voicing concerns around navigating the legal, financial and investment aspects, a new study by Fidelity International found. In the next 20 years, Australia is on track to transfer $3.5 trillion between generations ... |
| | | | ... construction sector is lagging Australia's productivity levels by 49% and is helping fuel the affordable housing crisis. The study calculates the number of dwellings completed per hour by housing construction workers has declined by 53% since 1995 ... |
| | | | ... listed on the ASX and Nasdaq, announced overnight that its phase three clinical trial Combination OPT-302 with Aflibercept Study (COAST) in patients with wet age-related macular degeneration failed. This triggered a repayment event to investors that ... |
| | | | ... recorded consistent monthly net flows, but those flows also increased significantly over time. In the first six months of the study period, average monthly net flows were $260 million, rising to $1.1 billion in the final six months. Global X followed ... |
| | | | Close to 5000 European funds being marketed as ESG hold interests in companies involved in fossil fuels, research shows. Close to 5000 funds being marketed as ESG in Europe hold interests in companies involved in fossil fuels, research shows. Analysing ... |
|